Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Review Article · Übersichtsarbeit

Editor's Choice - Free Access

Mindfulness-Based Stress Reduction for Integrative Cancer Care – a Summary of Evidence

Musial F.a · Büssing A.b · Heusser P.b · Choi K.-E.c · Ostermann T.b

Author affiliations

a The National Research Center in Complementary and Alternative Medicine (NAFKAM), Department of Community Medicine, Faculty of Health Science, University of Tromsø, Norway, b Center for Integrative Medicine, Faculty of Health, University of Witten/Herdecke, c Chair of Complementary and Integrative Medicine, University of Duisburg-Essen, Essen, Germany

Corresponding Author

Frauke Musial, PhD, The National Research Center in Complementary and Alternative Medicine (NAFKAM), Department of Community Medicine, Faculty of Health Sience, University of Tromsø, 9037 Tromsø, Norway, Tel. +47 7764-9282, Fax -6647, frauke.musial@uit.no

Related Articles for ""

Forsch Komplementmed 2011;18:192–202

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.


This paper provides a comprehensive overview of the relevant existing evidence, and critically appraises the use of mindfulness-based stress reduction (MBSR) in cancer care. Furthermore, a meta-analysis was conducted in order to investigate the effect of MBSR on quality of life (QoL), mood, and distress. Besides 6 reviews (5 systematic, 1 meta-analytic) which are reported separately, a total of 19 original research papers fully met the inclusion criteria for the systematic review. The 19 original papers consisted of 5 randomised controlled trials (RCTs), 4 non-randomised controlled trials (NRCTs), 9 observational studies (OS) and 1 two-arm observational study. The included outcome measures were QoL, mood, and distress. Cohen’s effect size d was computed for each category. Estimating the effect on QoL, a total of n = 248 patients out of 6 studies was included and the overall effect size was 0.29 (95% confidence interval (CI) 0.17–0.40; p ≤ 0.00005). Calculating the effect on mood, a total of n = 411 patients out of ten studies were included, and the overall effect size was 0.42 (95% CI 0.26–0.58; p < 0.0001). Reduction in distress revealed an overall effect size of 0.58 (95% CI 0.45–0.72; p < 0.0001; n = 587 patients out of 15 studies). MBSR programmes can improve QoL and mood, and reduce distress in cancer patients. However, there is an urgent need for more high quality RCTs implementing adequate controls, longer follow-up periods, sufficient samples sizes, clear descriptions of patients’ psychological profiles, and the accompanying utilisation of qualitative measures.

© 2011 S. Karger AG, Basel

Article / Publication Details

First-Page Preview
Abstract of Review Article &#x00B7; &#x00DC;bersichtsarbeit

Published online: August 08, 2011
Issue release date: August 2011

Number of Print Pages: 11
Number of Figures: 0
Number of Tables: 0

ISSN: 2504-2092 (Print)
eISSN: 2504-2106 (Online)

For additional information: https://www.karger.com/CMR

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.